welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
Healthcare Providers

Robert C. Griggs, MD

Healthcare Provider
University of Rochester Medical Center
601 Elmwood Ave
Box CU 420669
Rochester, New York, United States

Dr. Robert Griggs is an internist/neurologist specializing in neuromuscular diseases at University of Rochester Medical Center, with a focus on experimental therapeutics. He is also a Professor of Neurology in the Department of Pediatrics at the University of Rochester, School of Medicine and Dentistry.

Dr. Griggs currently serves on the Board of Directors of the American Academy of Neurology, the American Academy of Neurology Foundation, and the American Society for Experimental NeuroTherapeutics (ASENT). He Chairs the External Advisory Committee for Centre for Neuromuscular Diseases at the National Hospital for Neurology and Neurosurgery Queen Square, England and the NEMO Center, Milan, Italy.

Dr. Griggs’ research interests are focused on developing new treatments for neuromuscular diseases. He has developed treatments for the periodic paralyses, non-dystrophic myotonia, Duchenne muscular dystrophy and inflammatory myopathies. He has directed an NIH-funded training program in the experimental therapeutics of neurological disease. Dr. Griggs is currently principal investigator of NIH-funded studies also.


Representative Publications:

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review

Corticosteroids in Duchenne muscular dystrophy: major variations in practice

SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment